GWAYF (Greenway Greenhouse Cannabis) EPS without NRI: $0.00 (TTM As of Dec. 2025)


GWAYF Greenway Greenhouse Cannabis Corp GWAYF
24 GF Score
Price $0.27
GF Value $0.29
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is Greenway Greenhouse Cannabis EPS without NRI?

Greenway Greenhouse Cannabis GWAYF 24 EPS without NRI is $0.00 as of Dec. 2025. GuruFocus rates GWAYF with a GF Score™ of 24/100 and a GF Value™ of $0.29 (Fairly Valued). The stock has 5 warning signs investors should review. Among 786 Drug Manufacturers companies, Greenway Greenhouse Cannabis ranks worse than 80.28% on this metric.

Greenway Greenhouse Cannabis's earnings per share without non-recurring items for the three months ended in Dec. 2025 was $0.00. Its earnings per share without non-recurring items for the trailing twelve months (TTM) ended in Dec. 2025 was $0.00.

During the past 3 years, the average earnings per share (NRI) Growth Rate was -15.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using Earnings per share without Non-Recurring Items (NRI) data.

The historical rank and industry rank for Greenway Greenhouse Cannabis's EPS without NRI or its related term are showing as below:

GWAYF' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -56   Med: -35.7   Max: -15.4
Current: -15.4

During the past 5 years, Greenway Greenhouse Cannabis's highest 3-Year average Earnings Per Share (NRI) Growth Rate was -15.40% per year. The lowest was -56.00% per year. And the median was -35.70% per year.

GWAYF's 3-Year EPS without NRI Growth Rate is ranked worse than
80.28% of 786 companies
in the Drug Manufacturers industry
Industry Median: 9.6 vs GWAYF: -15.40

Greenway Greenhouse Cannabis's EPS (Diluted) for the three months ended in Dec. 2025 was $0.00. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was $0.00.

Greenway Greenhouse Cannabis's EPS (Basic) for the three months ended in Dec. 2025 was $0.00. Its EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2025 was $0.00.


Greenway Greenhouse Cannabis  (OTCPK:GWAYF) EPS without NRI Explanation

EPS without NRI removes onetime and unusual items from EPS, to provide investors with a more accurate measure of the company’s true earnings. The earnings are adjusted for items that are irregular or unusual in nature, and/or are non-recurring. This is calculated using Net Income (Continuing Operations) plus/minus any tax affected unusual Items and Goodwill Impairments/Write Offs. This can be used to fairly measure a company's profitability.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Greenway Greenhouse Cannabis EPS without NRI Related Terms


Greenway Greenhouse Cannabis EPS without NRI Historical Data

* Premium members only.

The historical data trend for Greenway Greenhouse Cannabis's EPS without NRI can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Greenway Greenhouse Cannabis EPS without NRI Chart

Greenway Greenhouse Cannabis Annual Data
Trend Mar21 Mar22 Mar23 Mar24 Mar25
EPS without NRI
-0.01 -0.01 -0.02 -0.03 -0.01

Greenway Greenhouse Cannabis Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
EPS without NRI Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.01 0.00 0.00 0.00 0.00

GWAYF vs ZTS, UTHR: EPS without NRI Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Greenway Greenhouse Cannabis's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Greenway Greenhouse Cannabis PE Ratio without NRI vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Greenway Greenhouse Cannabis's PE Ratio without NRI distribution charts can be found below:

* The bar in red indicates where Greenway Greenhouse Cannabis's PE Ratio without NRI falls into.


GWAYF
24GF Score
Greenway Greenhouse Cannabis Corp GWAYF
EPS without NRI is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Greenway Greenhouse Cannabis EPS without NRI Calculation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Earnings Per Share without Non-Recurring Items is the amount of earnings without non-recurring items per outstanding share of the company's stock.

EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS without NRI →
What does a EPS without NRI of $0.00 mean?
Greenway Greenhouse Cannabis (GWAYF) has a EPS without NRI of $0.00 as of Dec. 2025. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Greenway Greenhouse Cannabis and its competitors. According to the industry distribution chart, Greenway Greenhouse Cannabis ranks #631 out of 786 companies in the Drug Manufacturers industry, placing it in the top 80.3%.
Is Greenway Greenhouse Cannabis' EPS without NRI too high?
Greenway Greenhouse Cannabis' current EPS without NRI is $0.00. Based on the distribution chart, Greenway Greenhouse Cannabis ranks #631 out of 786 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Greenway Greenhouse Cannabis has a GF Score™ of 24/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Greenway Greenhouse Cannabis' EPS without NRI compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Greenway Greenhouse Cannabis ranks #631 out of 786 companies for EPS without NRI. This places Greenway Greenhouse Cannabis in the lower half of its industry. The industry median EPS without NRI is 9.60. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS without NRI for a Drug Manufacturers company?
The median EPS without NRI among Drug Manufacturers companies is 9.60, based on 786 companies in the industry. Companies in the top quartile (top 25%) have a EPS without NRI significantly above this median, while those in the bottom quartile fall well below. However, EPS without NRI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS without NRI mean?
A high EPS without NRI can signal that a stock is expensive relative to its fundamentals. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Greenway Greenhouse Cannabis and its competitors. For the Drug Manufacturers industry, the median EPS without NRI is 9.60 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Greenway Greenhouse Cannabis's current EPS without NRI is $0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Greenway Greenhouse Cannabis stock overvalued right now?
Based on GuruFocus' analysis, Greenway Greenhouse Cannabis (GWAYF) is currently considered Fairly Valued. The stock's GF Value™ is $0.29, compared to a current price of $0.27 — trading 6.7% below its estimated fair value. The current EPS without NRI is $0.00. Greenway Greenhouse Cannabis' overall GF Score™ is 24/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS without NRI calculated?
EPS without NRI is calculated from a company's financial statements. For Greenway Greenhouse Cannabis (GWAYF), the current EPS without NRI is $0.00 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Greenway Greenhouse Cannabis (GWAYF) Overvalued in 2026?

Based on GuruFocus' analysis, Greenway Greenhouse Cannabis stock appears to be undervalued. The current stock price of $0.27 is trading 6.7% below its estimated GF Value™ of $0.29. GuruFocus considers Greenway Greenhouse Cannabis to be Fairly Valued.

Key valuation signals for GWAYF:

  • EPS without NRI: $0.00
  • GF Value™: $0.29 vs. price of $0.27 (6.7% below fair value)
  • GF Score™: 24/100 with 5 warning signs

No single metric tells the full story. See the GWAYF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Greenway Greenhouse Cannabis Business Description

Other Exchanges GWAY:Canada
Address 1478 Seacliff Drive, Kingsville, ON, CAN, N9Y 2M2
Greenway Greenhouse Cannabis Corp is licensed to cultivate, process and sell to ensures harvests always consist of the highest quality cannabis strains with resinous flowers, trichomes, and rich cannabinoid profiles. The Company's nursery facility is located in Kingsville, Ontario, and its flowering and processing facility is located in Leamington, Ontario. The business model is to supply bulk packaged, high quality cannabis to the Canadian, cannabis industry at prices that ultimately provide a value proposition to the consumers. Greenway has three divisions with various locations; Greenway Nursery, Greenway Cultivation and future plans for Greenway Farmgate Retail Store.
24GF Score

Get the complete analysis for GWAYF

EPS without NRI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.27
Price
$0.29
GF Value